CLS carries out a directed issue to guarantors in connection with completed exercise of warrants
The board of directors of Clinical Laserthermia Systems AB ("CLS" or the "Company") has, in accordance with the guarantee agreements entered into in connection with the exercise of the Company's warrants of series TO 7B ("Warrant Exercise"), decided on a directed issue to the parties who have provided guarantees in the Warrant Exercise and who have chosen to receive guarantee compensation in the form of newly issued B-shares in the Company ("Compensation Issue"). The subscription price in the Compensation Issue is, in accordance with the terms of the guarantee agreements, set at SEK 3.68 per